French doctors in clinical trials have found a cure for the deadly symptom COVID-19, announced in a hospital organization Assistance publique – Hopitaux de Paris (AP-HP).
In particular, testing of the drug for rheumatoid arthritis has demonstrated its effectiveness in the fight against one of the potentially fatal symptoms caused by coronavirus infection is a new type of disease — hypercytokinemia (cytokine storm). It is considered that patients with the relevant disease are suffering from acute respiratory failure.
According to the doctors from France, the first results relate to the sample of controlled multicenter test tocilizumab — a monoclonal antibody that blocks the receptor for the cytokine interleukin-6 and applied, including in the treatment of rheumatoid arthritis.
the study involved 129 patients. 65 in addition to standard treatment regimens, I took this drug and other 64 acted as the control group and received only normal treatment. Based on observations the doctors came to the conclusion that fewer patients were in critical condition.
Read the article: “Named the most vulnerable COVID-19 blood group”
